• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在一名接受异基因造血干细胞移植的白血病患者中,通过基因分析快速鉴定病原体成功治疗播散性诺卡菌病。

Successful Treatment of Disseminated Nocardiosis by Rapid Identification of the Organism via Genetic Analysis in a Leukemia Patient Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.

作者信息

Anan Tomoe, Takahashi Yasuyuki, Kimura Yuta, Tabayashi Takayuki, Kubota Yasushi

机构信息

Department of Hematology, Saitama Medical University, Saitama Medical Center, Kawagoe, JPN.

出版信息

Cureus. 2024 Apr 17;16(4):e58489. doi: 10.7759/cureus.58489. eCollection 2024 Apr.

DOI:10.7759/cureus.58489
PMID:38765332
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11101261/
Abstract

infections have been reported to occur in immunocompromised patients. Early diagnosis and therapeutic intervention are especially important for disseminated nocardiosis because of its high mortality rate. A case of disseminated nocardiosis after allogeneic hematopoietic stem cell transplantation, which was promptly treated after identification of the organism by genetic analysis, is presented. A 43-year-old man was diagnosed with T-cell prolymphocytic leukemia and underwent allogeneic hematopoietic stem cell transplantation. Subsequently, during long-term prednisolone administration for chronic graft-versus-host disease, he developed mass lesions throughout his body at 1033 days after transplantation. Pus culture and genetic testing of the parotid mass showed , which improved with treatment with sulfamethoxazole, trimethoprim, and imipenem cilastatin, and there has been no recurrence. When multiple mass lesions occur after hematopoietic stem cell transplantation, and the diagnosis is difficult, disseminated nocardiosis should be included in the differential diagnosis, and appropriate laboratory testing and treatment should be performed.

摘要

据报道,免疫功能低下的患者会发生感染。由于播散性诺卡菌病死亡率高,早期诊断和治疗干预尤为重要。本文介绍了1例异基因造血干细胞移植后发生播散性诺卡菌病的病例,该病例在通过基因分析鉴定出病原体后得到了及时治疗。一名43岁男性被诊断为T细胞原淋巴细胞白血病,并接受了异基因造血干细胞移植。随后,在长期使用泼尼松龙治疗慢性移植物抗宿主病期间,他在移植后1033天全身出现肿块病变。腮腺肿块的脓液培养和基因检测显示……,经磺胺甲恶唑、甲氧苄啶和亚胺培南西司他丁治疗后病情好转,且未复发。当造血干细胞移植后出现多个肿块病变且诊断困难时,应将播散性诺卡菌病纳入鉴别诊断,并进行适当的实验室检查和治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37ac/11101261/bc52f34c91b9/cureus-0016-00000058489-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37ac/11101261/afc78bd4a40e/cureus-0016-00000058489-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37ac/11101261/9a5afcb73a81/cureus-0016-00000058489-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37ac/11101261/bc52f34c91b9/cureus-0016-00000058489-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37ac/11101261/afc78bd4a40e/cureus-0016-00000058489-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37ac/11101261/9a5afcb73a81/cureus-0016-00000058489-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37ac/11101261/bc52f34c91b9/cureus-0016-00000058489-i03.jpg

相似文献

1
Successful Treatment of Disseminated Nocardiosis by Rapid Identification of the Organism via Genetic Analysis in a Leukemia Patient Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.在一名接受异基因造血干细胞移植的白血病患者中,通过基因分析快速鉴定病原体成功治疗播散性诺卡菌病。
Cureus. 2024 Apr 17;16(4):e58489. doi: 10.7759/cureus.58489. eCollection 2024 Apr.
2
Successful maintenance treatment of disseminated nocardiosis with cerebral abscess in a severely immunocompromised patient allergic to trimethoprim-sulfamethoxazole using moxifloxacin and high-dose minocycline: A case report.成功使用莫西沙星和高剂量米诺环素治疗对甲氧苄啶-磺胺甲恶唑过敏的严重免疫功能低下患者伴脑脓肿播散性奴卡菌病的维持治疗:一例报告。
J Infect Chemother. 2024 Dec;30(12):1319-1323. doi: 10.1016/j.jiac.2024.04.008. Epub 2024 Apr 24.
3
Risk Factors and Outcomes of Nocardiosis in Hematopoietic Stem Cell Transplantation Recipients.造血干细胞移植受者中诺卡氏菌病的危险因素和结局。
Transplant Cell Ther. 2023 Mar;29(3):206.e1-206.e7. doi: 10.1016/j.jtct.2022.12.004. Epub 2022 Dec 13.
4
Disseminated nocardiosis after unrelated bone marrow transplantation.非亲缘性骨髓移植后播散性诺卡菌病
Transpl Infect Dis. 2016 Dec;18(6):942-945. doi: 10.1111/tid.12617. Epub 2016 Nov 10.
5
The emergence of rare nocardiosis following allogeneic hematopoietic stem cell transplantation in the era of molecular taxonomy.在分子分类学时代,异基因造血干细胞移植后罕见的奴卡菌病的出现。
Int J Infect Dis. 2019 Dec;89:154-162. doi: 10.1016/j.ijid.2019.10.003. Epub 2019 Oct 9.
6
Disseminated nocardiosis caused by Nocardia farcinica in a patient with colon cancer: A case report and literature review.放线菌属 farcinica 引起的播散性诺卡氏菌病:病例报告及文献复习。
Medicine (Baltimore). 2021 Jul 23;100(29):e26682. doi: 10.1097/MD.0000000000026682.
7
Nocardiosis following hematopoietic stem cell transplantation.造血干细胞移植后诺卡菌病
Transpl Infect Dis. 2016 Apr;18(2):169-75. doi: 10.1111/tid.12499. Epub 2016 Mar 29.
8
Clarithromycin As an Alternative and Prophylactic Agent in a Hematopoietic Stem Cell Transplantation Patient.克拉霉素作为造血干细胞移植患者的替代和预防药物。
Am J Case Rep. 2021 Jun 15;22:e931731. doi: 10.12659/AJCR.931731.
9
Thyroid nocardiosis: Case report and review of the literature.甲状腺奴卡菌病:病例报告及文献复习。
Transpl Infect Dis. 2021 Aug;23(4):e13594. doi: 10.1111/tid.13594. Epub 2021 Mar 11.
10
Long-term use of liposomal nebulized amikacin and tedizolid for the treatment of disseminated nocardiosis after allogeneic hematopoietic stem cell transplantation.长期使用脂质体雾化阿米卡星和替加环素治疗异基因造血干细胞移植后播散性诺卡氏菌病。
Eur J Clin Microbiol Infect Dis. 2021 Sep;40(9):2033-2036. doi: 10.1007/s10096-021-04186-6. Epub 2021 Mar 10.

本文引用的文献

1
Nocardia Infections in Hematopoietic Cell Transplant Recipients: A Multicenter International Retrospective Study of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation.造血干细胞移植受者诺卡菌感染:欧洲血液和骨髓移植学会传染病工作组的一项多中心国际回顾性研究。
Clin Infect Dis. 2022 Aug 24;75(1):88-97. doi: 10.1093/cid/ciab866.
2
Pathophysiology of Chronic Graft-versus-Host Disease and Therapeutic Targets.慢性移植物抗宿主病的病理生理学及治疗靶点
N Engl J Med. 2017 Dec 28;377(26):2565-2579. doi: 10.1056/NEJMra1703472.
3
Nocardia infections in solid organ and hematopoietic stem cell transplant recipients.
实体器官和造血干细胞移植受者中的诺卡菌感染。
Curr Opin Infect Dis. 2017 Dec;30(6):545-551. doi: 10.1097/QCO.0000000000000404.
4
Outcome and Treatment of Nocardiosis After Solid Organ Transplantation: New Insights From a European Study.实体器官移植后诺卡菌病的结局与治疗:一项欧洲研究的新见解
Clin Infect Dis. 2017 May 15;64(10):1396-1405. doi: 10.1093/cid/cix124.
5
Nocardiosis following hematopoietic stem cell transplantation.造血干细胞移植后诺卡菌病
Transpl Infect Dis. 2016 Apr;18(2):169-75. doi: 10.1111/tid.12499. Epub 2016 Mar 29.
6
Pulmonary Nocardia nova infection after allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植后新诺卡氏菌肺部感染
Intern Med. 2014;53(12):1391-5. doi: 10.2169/internalmedicine.53.1860. Epub 2014 Jun 15.
7
Disseminated Nocardia farcinica: literature review and fatal outcome in an immunocompetent patient.播散性星型诺卡菌感染:免疫功能正常患者的文献复习和致死结局。
Surg Infect (Larchmt). 2012 Jun;13(3):163-70. doi: 10.1089/sur.2011.012. Epub 2012 May 21.
8
Nocardiosis: updates and clinical overview.奴卡菌病:最新进展和临床概述。
Mayo Clin Proc. 2012 Apr;87(4):403-7. doi: 10.1016/j.mayocp.2011.11.016.
9
Nocardiosis in Quebec, Canada, 1988-2008.1988-2008 年加拿大魁北克的诺卡氏菌病。
Clin Microbiol Infect. 2011 May;17(5):690-6. doi: 10.1111/j.1469-0691.2010.03306.x.
10
Nocardiosis: updated clinical review and experience at a tertiary center.奴卡菌病:三级中心的最新临床综述和经验。
Infection. 2010 Apr;38(2):89-97. doi: 10.1007/s15010-009-9193-9. Epub 2010 Mar 20.